Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Type of study
Language
Document Type
Year range
1.
Metab Brain Dis ; 38(3): 795-804, 2023 03.
Article in English | MEDLINE | ID: covidwho-2315296

ABSTRACT

Schizophrenia (SZ) is a devastating neurodevelopmental disease with an accelerated ageing feature. The criteria of metabolic disease firmly fit with those of schizophrenia. Disturbances in energy and mitochondria are at the core of complex pathology. Genetic and environmental interaction creates changes in redox, inflammation, and apoptosis. All the factors behind schizophrenia interact in a cycle where it is difficult to discriminate between the cause and the effect. New technology and advances in the multi-dispensary fields could break this cycle in the future.


Subject(s)
Metabolic Diseases , Schizophrenia , Humans , Schizophrenia/genetics , Schizophrenia/metabolism , Oxidation-Reduction , Aging , Mitochondria/metabolism , Metabolic Diseases/genetics , Metabolic Diseases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL